Open | 1.82 |
Previous Close | 1.79 |
Day Range | 1.82 - 1.96 |
52-Week Range | 1.07 - 4.62 |
All-Time High | 27.60 |
Avg. Volume (50-day) | 537,548.6 |
EPS (TTM) | -0.35 |
Next Earnings Date | 2025-08-07 (BMO) |
Last Earnings Date | 2025-05-08 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -5.14 |
PEG Ratio | - |
Price to Book | 2.21 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 20.36 M |
Revenue per Share (TTM) | 0.19 |
Shares Outstanding | 105.213 M |
Share Float (%) | 72.22 M |
% Held by Institutions | 40.17 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 1.71 (+11.70%) |
+/- SMA(50) | 1.51 (+26.49%) |
+/- SMA(200) | 2.29 (-16.59%) |
5-Day Perf. | +15.06% |
1-Month Perf. | +22.44% |
3-Month Perf. | -1.55% |
6-Month Perf. | -46.35% |
YTD Perf. | -27.92% |
1-Year Perf. | -4.02% |
RSI(14) | 65 |
ATR(14) | 0.12 |
ADX(14) | 27.68 |
Beta (5Y) | 1.27 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.
PRQR has triggered the following predefined scans:
Moved Above Upper Bollinger Band |
Moved Above Ichimoku Cloud |
Elder Bar Turned Green |
Moved Above Upper Price Channel |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.